A comprehensive view of Branded Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Patent Issued for Protein solution formulation containing high concentration of an anti-VEGF antibody (USPTO 11945859)
Published: April 19, 2024 by Angiogenesis Daily
US Dept. of Justice files complaint alleging fraudulent drug pricing practices by Regeneron for its ophthalmology drug Eylea that cost Medicare hundreds of millions of dollars
Published: April 12, 2024 by Zack's Commentary
Commentary: Excessive costs on GLP-1 medications from Eli Lilly and Novo Nordisk have led to their inaccessibility in low-/middle-income nations; report finds if branded companies were to partner with generics makers, prices could be less than US$1/month
Published: April 08, 2024 by Indian Pharma Industry: Policies
FDA approves J&J’s CARVYKTI to treat patients with relapsed or refractory multiple myeloma who have received at least one prior line of therapy; an estimated 35,000 cases of the disease projected to be diagnosed this year in US
Published: April 06, 2024 by Janssen Pharmaceutical Companies
Moderna COVID-19 vaccine reduces symptomatic infection in adults aged 18-19, Texas A&M University study shows; study finds slightly lower efficacy than other studies, with 53% effectiveness against infection, 71% against symptomatic illness
Published: February 01, 2024 by Targeted News Service

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count